Skip to main content
. 2021 Feb 16;5(4):1017–1028. doi: 10.1182/bloodadvances.2020003508

Figure 2.

Figure 2.

Response stratified by TET2 and ASXL1 genotype. Comparison of overall response rate (A) and complete remission rate (B) among combinations of TET2 and ASXL1 genotypes (TET2-mutated [mut]/ASXL1-wt [wild-type], n = 29; TET2-wt/ASXL1-wt, n = 159; ASXL1-mut, n = 47). The vertical axis represents the frequency of response and comparisons between specific groups are annotated. *Denotes statistical significance (P < .05).